Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary Matrix-M adjuvant technology for use in up to two disease areas. The ...
Airlines have upgraded plenty of their tech, yet these old-school printers from the 1980s are still hanging on for a few very ...
(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...
Q: When doing posterior composites, what are you using for your class II matrix? A: There are a lot of matrix systems available that all claim to create the perfect morphology and contact with ...
The Matrix Model, developed by the Matrix Institute (now CLARE|MATRIX), is one of the few treatment models specifically designed to address the needs of individuals with stimulant-use disorders. This ...
Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results